Pompano Beach, Sept. 11, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group, Inc. (NASDAQ:DSKX), a leading developer of personal care products, today announced it has launched its Brazilian website: http://dslabshop.com.br. The e-commerce site provides convenient online shopping for Brazilians. The site also offers extensive product information to support in-stores sales of its products.
DS Healthcare recently expanded the distribution of its products into Brazil's CSB Drogaria which operates two retail pharmacy chains, Drogasmil and Farmalife with stores primarily located in the Rio de Janeiro metropolitan area.
"Our new e-commerce site in Brazil reaches the country's broader population. Our 10 best-selling SKUs approved for commercialization are currently being sold in the Brazilian market through retail stores in one key metropolitan area and we expect our national reach through e-commerce will further increase exposure and sales of our products," stated DS Healthcare President and CEO Daniel Khesin. "We've seen through our initial pilot programs that our product line, particularly our hair growth products are ideally suited for the Brazilian consumer."
According to Euromonitor, a market research firm, the Brazilian beauty industry generated $43 billion in sales in 2011, an increase of 19% over the prior year.
About DS Healthcare Group
DS Healthcare Group Inc. leads in the development and distribution of topical therapies for personal care, including what management believes is the world's most effective topical treatment for hair loss. Its products are sold through a network of salons, pharmacies, online retailers, specialty retailers and select department stores. Its brands include DS Laboratories(www.DSLaboratories.com), Sigma Skin (www.(www.SigmaSkin.com), Polaris Research Laboratories (www.PolarisResearchLabs.com) The Pure Guild (www.ThePureGuild.com) and Nutra Origin (www.NutraOrigin.com)
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov.
CONTACT: Contact: Laurel Moody Corporate Profile 1.646.810.0608 Source:DS Healthcare Group,Inc.